Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV001536201 | SCV001752924 | likely benign | not provided | 2021-10-24 | criteria provided, single submitter | clinical testing | |
Genetic Services Laboratory, |
RCV001821857 | SCV002069739 | benign | not specified | 2021-02-12 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001536201 | SCV003283446 | benign | not provided | 2025-01-08 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004980588 | SCV005563823 | likely benign | Inborn genetic diseases | 2024-08-21 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Prevention |
RCV003908888 | SCV004725889 | likely benign | DDX41-related disorder | 2020-01-02 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |